Product
Supplier
Encyclopedia
Inquiry
Sitagliptin phosphate 99% buy - large image1
Sitagliptin phosphate 99% buy - image1

Sitagliptin phosphate 99%

2 Inquiries

Unit Price:

$1/MT FOB

Get Latest Price
CAS No.:

654671-77-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SHANGHAI

Packaging:

25kg/1.3kg Carton

Price valid (until):

2056-11-09

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Imatinib mesylate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Sitagliptin phosphate monohydrate, molecular formula C16H20F6N5O6P, a new hypoglycemic dipeptidyl peptidase-4 of sitagliptin phosphate.

    English name: Sitagliptin phosphate monohydrate

    CAS number: 654671-77-9

    Molecular formula: C16H20F6N5O6P

    Molecular weight: 523.3240802

    other name :7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)Butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazinephosphatemonohydrate;Sitagliptin phosphate monohydrate;Sitagliptin phosphate for research;D06645;Januvia (tn);Sitagliptin phosphate (usan);Sitagliptin phosphate hydrate;Sitagliptin phosphate hydrate (jan)


    Basic Info
    Product Name:

    Sitagliptin phosphate monohydrate

    Other Name:

    1-Butanone,3-amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-,(3R)-,phosphate,hydrate (1:1:1);1,2,4-Triazolo[4,3-a]pyrazine,7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-,phosphate (1:1),monohydrate;(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine dihydrogen phosphate monohydrate;Sitagliptin phosphate monohydrate;1253056-03-9

    CAS No.:

    654671-77-9

    Molecular Formula:

    C16H15F6N5O.H3O4P.H2O

    InChIKeys:

    InChIKey=GQPYTJVDPQTBQC-KLQYNRQASA-N

    Molecular Weight:

    523.3240802

    Exact Mass:

    523.105530

    EC Number:

    1806241-263-5

    UNII:

    TS63EW8X6F

    NCI Thesaurus Code:

    C73811

    ATC Code:

    A10BH01|A10BD24

    HScode:

    2933990090

    Categories:

    Inhibitor Drugs

    Characteristics
    PSA:

    156

    XLogP3:

    1.66180

    Appearance:

    White or almost white crystalline powder

    Boiling Point:

    529.9ºC at 760 mmHg

    Flash Point:

    274.3℃

    Hazard Identification

    Classification of the substance or mixture

    Eye irritation, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H319 Causes serious eye irritation

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

    Storage

    none

    Disposal

    none

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Imatinib mesylate

    Location:

    No.21,HuanCheng West Road ,AnQing City ,Anhui Province,China

    Payment Terms:

    D/P,L/C,D/A

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2009

    Certifications:

    business license,ISO9001

    ANHUI HAIKANG PHARMACEUTICAL CO.,LTD. was established in 2009 in Anqing City, Anhui Province. It is located along the north bank of mid and lower reaches of the Yangtze River. Enjoying favorable  geographic superiorities and convenient transportation infrastructure: such as highway, high speed railway, airport, inland shipping container terminal and so on. By plane, it takes just 1 hour to Shanghai, 2 hours to Guangzhou or Beijing; by high speed train it takes 2 hours to reach Nanjing, 4 hours to Shanghai, 6.5 hours Beijing.Since founded the company has been committed to the production, sales and export of chemical raw materials of pharmaceutical APIs and intermediates, while as well as other services of product customization, process improvement, achievement transfer,etc.

    The company covers an area of 28000 square meters. We invested 80 million Yuan to set up 3 synthesis workshops and 3 purification workshops, whose annual output value is over hundred million Yuan, and their profits and taxes are over 20 million Yuan. All our productions are in strict accordance with GMP standard and we have established a well-equipped R & D center.

    Haikang currently employs 50 people. 2 of them are of doctoral degree, 6 of master degree,1 researcher returned from overseas and all the rest employees have at least college education. We have close cooperation with Zhejiang University of Technology, University of Science and Technology of China and Anhui University of Chinese Medicine ,etc. We have an academic advisors team consisting of experts and professors who have well background of medical profession and ample experience in pharmacy developing and marketing. It is a united, hard-working, courageous, rigorous and innovative team of elites.

    Through years of unremitting efforts Haikang has made remarkable achievements in the R&D and production of anti-virus, antidiabetic series APIs and intermediates. The main products are ganciclovir, valganciclovir hydrochloride, valaciclovir HCL, silodosin, repaglinide, sitagliptin, imatinib and their intermediates. We have established long and stable relationship with nearly 100 domestic and international pharmaceutical manufacturers and research institutes.

    To deal with increasingly fierce competition and challenges of economic globalization, Haikang adheres to the business philosophy of “Customer is First, Technology is Leading, Quality is Everything, Honesty for Development” and insists on developing scientifically, globally and diversely. Relying on our existing advantages, we focus on the integration of various resources, and actively optimize the system of decision-making, management and service. We keep up with the pace of the newest R&D trend in and outside China; keep continuous innovation to develop high-tech, market prospective products to satisfy different needs from different customers. While pursuing economic benefits, Haikang has also committed to spare no efforts to advanced environmental management. It is always a mission and moreover a responsibility for Haikang to take care of people’s health and protect the environment.

    We have confidence in our future and looking forward to having sincere, win-win and brilliant cooperation with you!


  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Bangladesh

    Sitagliptin phosphate 99%

    50 KG Nov 13, 2023
    Egypt

    Sitagliptin phosphate monohydrate

    3.00 KG Oct 11, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.